Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat Regimens in Relapsed/Refractory Multiple Myeloma
NCT02654990Phase 2Completed
- Sponsor
- pharma&
- Start
- Apr 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 2 trial of panobinostat in multiple myeloma (MM), sponsored by pharma&. Started Apr 2016; status: completed.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02654990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654990.